Financial results - DOCTOR ROBI S.R.L.

Financial Summary - Doctor Robi S.r.l.
Unique identification code: 14963680
Registration number: J05/1035/2002
Nace: 8621
Sales - Ron
75.616
Net Profit - Ron
27.284
Employee
2
The most important financial indicators for the company Doctor Robi S.r.l. - Unique Identification Number 14963680: sales in 2023 was 75.616 euro, registering a net profit of 27.284 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Doctor Robi S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 52.053 54.733 56.901 57.462 80.930 46.661 55.992 56.423 56.635 75.616
Total Income - EUR 52.132 54.869 56.903 57.714 86.809 46.661 55.992 56.424 56.636 75.617
Total Expenses - EUR 33.244 48.310 51.534 49.659 79.931 64.993 57.945 51.318 39.505 47.667
Gross Profit/Loss - EUR 18.887 6.559 5.369 8.055 6.878 -18.332 -1.953 5.105 17.131 27.949
Net Profit/Loss - EUR 17.323 4.912 4.664 6.190 6.010 -18.798 -2.512 4.552 16.576 27.284
Employees 6 6 3 3 1 1 1 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 33.9%, from 56.635 euro in the year 2022, to 75.616 euro in 2023. The Net Profit increased by 10.758 euro, from 16.576 euro in 2022, to 27.284 in the last year.

Check the financial reports for the company - Doctor Robi S.r.l.

Rating financiar

Financial Rating -
Doctor Robi S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Doctor Robi S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Doctor Robi S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Doctor Robi S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Doctor Robi S.r.l. - CUI 14963680

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 3.086 11.415 9.871 8.354 18.698 21.715
Current Assets 134.315 132.251 46.404 40.036 38.431 36.147 40.307 52.163 35.821 44.902
Inventories 0 0 144 516 0 0 1.853 2.236 0 0
Receivables 79.028 78.762 30.282 31.602 28.730 28.518 30.999 36.917 30.115 37.514
Cash 55.287 53.490 15.979 7.917 9.700 7.628 7.456 13.010 5.706 7.387
Shareholders Funds 108.959 105.139 68.882 60.080 64.854 44.800 41.438 45.072 22.714 49.929
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 25.356 27.113 25.734 27.351 25.049 50.210 55.288 60.962 77.463 62.207
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 44.902 euro in 2023 which includes Inventories of 0 euro, Receivables of 37.514 euro and cash availability of 7.387 euro.
The company's Equity was valued at 49.929 euro, while total Liabilities amounted to 62.207 euro. Equity increased by 27.284 euro, from 22.714 euro in 2022, to 49.929 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Doctor Robi S.r.l.

Comments - Doctor Robi S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.